Conference Coverage: Annual Meeting of the Consortium of Multiple Sclerosis Centers

Conference Coverage

Teriflunomide effective for faster-advancing MS

Key clinical point: Teriflunomide is effective for patients with faster-advancing MS. Major finding: Teriflunomide at 14 mg and 7 mg reduced the...

Conference Coverage

Smoking causes worse outcome in MS

Key clinical point: Smoking increases the risk of developing multiple sclerosis and worsens the severity of the disease. Major finding: Regular...

Conference Coverage

Optimizing treatment selection in MS often tricky

Important factors to consider when choosing an appropriate disease-modifying therapy for patients with multiple sclerosis include disease activity...

Conference Coverage

CMSC: Survey offers snapshot of MS therapy trends

One-quarter of multiple sclerosis patients receive some form of assistance from the pharmaceutical industry in covering the cost of their disease-...

Conference Coverage

CMSC: Many menopausal and MS symptoms overlap

While about half of females with multiple sclerosis are postmenopausal, objective data about the impact of menopause on the course of multiple...

Pages